Red X iconGreen tick iconYellow tick icon

8th Pharmacoepidemiology Research Network Symposium

Wednesday, 27 November 2024, 10:00am – 4:30pm
St Margaret’s College, Dunedin | Ōtepoti

Download the programme (PDF)

 
10:00am – 10:10am Mihi whakatau
Maioha Watson, Office of Māori Development, University of Otago – Ōtākou Whakaihu Waka
Opening remarks
Lianne Parkin, Department of Preventive and Social Medicine | Te Tari Hauora Tūmatanui, University of Otago – Ōtākou Whakaihu Waka; New Zealand Pharmacovigilance Centre
Session One Chair: Lianne Parkin
10:10am – 11:00am History of pharmacoepidemiology and drug safety research: how and where it began
Susan Jick, Boston Collaborative Drug Surveillance Program
11:00am – 11:30am Morning tea
Session Two Chair: Karyn Maclennan
11:30am – 11:45am Exposure to systemic antimicrobials during pregnancy and risk of miscarriage: a population-based register study.
Thomas Boissiere-O’Neill, Child Health Research Centre, University of Queensland
11:45am – 12:00pm The association between nitrate in drinking water during pregnancy and adverse pregnancy outcomes: potential effect modification by nitrosatable drug intake.
Tim Chambers, Ngāi Tahu Research Centre, University of Canterbury| Te Whare Wānanga o Waitaha
12:00pm – 12:15pm Use of antinausea medications during the first trimester of pregnancy in Aotearoa New Zealand, 2005–2020
Sarah Donald, Department of Preventive and Social Medicine | Te Tari Hauora Tūmatanui, University of Otago – Ōtākou Whakaihu Waka
12:15pm – 12:30pm Validation of small for gestational age coded diagnoses in Aotearoa New Zealand’s administrative health datasets
Mei-Ling Blank, Department of Preventive and Social Medicine | Te Tari Hauora Tūmatanui, University of Otago – Ōtākou Whakaihu Waka
12:30pm – 1:30pm Lunch
Session Three Chair: Katrina Sharples
1:30pm – 2:15pm Overview of pharmacoepidemiology methods for drug safety studies: key methodological considerations
Susan Jick, Boston Collaborative Drug Surveillance Program
2:15pm – 2:30pm Colchicine poisoning in Aotearoa New Zealand: using data to gather insights and inform actions.
Nevin Zhong and Tegan Coventry, Clinical Risk Management Branch, Medsafe
2:30pm – 2:45pm The long-term effects of opioid use before total joint replacement surgery: a dose-response trial emulation with New Zealand linked administrative data.
Ross Wilson, Department of Surgical Sciences| Te Tari Hāparapara, University of Otago – Ōtākou Whakaihu Waka
2:45pm – 3:00pm A systematic review of global long-term cost-effectiveness of newer antidiabetic drugs: trends in type 2 diabetes mellitus research.
Dan Li, School of Pharmacy | He Rau Kawakawa, University of Otago – Ōtākou Whakaihu Waka
3:00pm – 3:30pm Afternoon tea
Session Four Chair: Simon Horsburgh
3:30pm – 3:45pm How does risk communication by pharmacists impact how people with asthma perceive and respond to risk?
Eliza J. McEwin, School of Pharmacy and Charles Perkins Centre, University of Sydney
3:45pm – 4:00pm Drug use evaluations for Australia’s Pharmaceutical Benefits Scheme to assess quality use of medicines: a document analysis study.
Judith Mackson, School of Pharmacy and Charles Perkins Centre, University of Sydney
4:00pm – 4:15pm Systematic reviews of observational studies of harms of medicines: a case study of application of two risk of bias tools within a controversial research area.
Barbara Mintzes, School of Pharmacy and Charles Perkins Centre, University of Sydney
4:15pm – 4:25pm Is it really 10 years?
Lianne Parkin, Department of Preventive and Social Medicine | Te Tari Hauora Tūmatanui, University of Otago – Ōtākou Whakaihu Waka; New Zealand Pharmacovigilance Centre
4:25pm – 4:30pm Karakia Whakamutunga
Maioha Watson, Office of Māori Development, University of Otago – Ōtākou Whakaihu Waka
6:00pm Informal dinner
Back to top